Direktorat Registrasi ObatValid

CATAPRES

Claim this product
BPOM Number
DKI2565700343A1
Approved
29 November 2025
Expiry
1 August 2029
Form
INJEKSI

About This Registration

CATAPRES is a BPOM-registered direktorat registrasi obat in Indonesia, registered under number DKI2565700343A1. Its current registration status is Valid, with the licence valid until 1 August 2029. The product is registered to TUNGGAL IDAMAN ABDI - INDONESIA. BPOM first approved this registration in November 2025. All registration data is sourced directly from the official BPOM public database and updated daily.

Registration Details

Application
newaero
Packaging
DUS, 10 AMPUL @ 1 ML
Department
Direktorat Registrasi Obat

Retail Audit Service

Get detailed market intelligence for this product across Indonesian retail channels

Multiple cities available
Custom questionnaires
Professional shoppers
Detailed reporting
Starting from $50 per city
What's included in the audit service?

Stock availability and positioning verification

Price checking and competitor analysis

Display quality and promotional material assessment

Store condition and customer experience evaluation

Custom questions tailored to your research needs

Professional photographs and detailed reports

Registered Owners

Ingredients (1)

CLONIDINE HYDROCHLORIDE

Market Intelligence

Owner Portfolio
TUNGGAL IDAMAN ABDI - INDONESIA holds 126 BPOM registrations
Manufacturer Scale
TUNGGAL IDAMAN ABDI - INDONESIA produces 126 registered products
Registration Age
Registered for 9 months

FDA Cross-Reference

via openFDA
Generic Name
CLONIDINE TRANSDERMAL SYSTEM
Product Type
HUMAN PRESCRIPTION DRUG
Route of Administration
TRANSDERMAL

Data sourced from the U.S. FDA drug label database (openFDA). May not exactly match this product variant.

Is this your product?

Claim it to manage registration, track renewals, and get expiry alerts.

Claim Product

More products from TUNGGAL IDAMAN ABDI - INDONESIA

ULTRAPROCT N

-DKI2671700129A1
Valid
Approved: Apr 10, 2026KRIM
View product →

ROJUSNA

-DKI2668900244B1
Valid
Approved: Jun 23, 2026SERBUK INJEKSI LIOFILISASI
View product →

ROJUSNA

-DKI2668900244A1
Valid
Approved: Jun 23, 2026SERBUK INJEKSI LIOFILISASI
View product →

SPIOLTO RESPIMAT

-DKI2500700868A1
Valid
Approved: Dec 23, 2025CAIRAN INHALASI
View product →

IMMUNINE

-DKI2563500544A1
Valid
Approved: Dec 22, 2025SERBUK DAN PELARUT UNTUK INJEKSI ATAU INFUS
View product →

Products in the same class

DIMENHYDRINATE

-GTL2128919410A1
Valid
Approved: May 11, 2026TABLET
RAMA EMERALD MULTI SUKSES - INDONESIA
View product →

VOLEQUIN

-DKL0105029917B1
Valid
Approved: Mar 29, 2026TABLET SALUT SELAPUT
DEXA MEDICA - INDONESIA
View product →

DOSIVEC

-DKL1615624838A1
Valid
Approved: Mar 29, 2026SUSPENSI KERING
MEPROFARM
View product →

EFLAGEN 50

-DKL9722222016B1
Valid
Approved: Mar 18, 2026TABLET SALUT GULA
SANBE FARMA
View product →

LUXAMET

-DTL2209226929A1
Valid
Approved: Feb 13, 2026KRIM
IFARS PHARMACEUTICAL LABORATORIES - INDONESIA
View product →
1